RVTY
Revvity, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth +5.6% ·
share flow +0.6% ·
net new positions 0.0%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 131 | +9 | 65.85M | $7.33B | +14 | −6 |
| Q1 2026 | 126 | -7 | 72.99M | $6.39B | +4 | −12 |
| Q4 2025 | 133 | 0 | 75.39M | $7.30B | +3 | −2 |
| Q3 2025 | 19 | +1 | 44.69M | $3.92B | +1 | −1 |
| Q2 2025 | 16 | +1 | 42.02M | $4.06B | +3 | −2 |
| Q1 2025 | 12 | -1 | 20.50M | $2.17B | n/a | −1 |
| Q4 2024 | 13 | 0 | 18.11M | $2.02B | +1 | −1 |
| Q3 2024 | 12 | -1 | 11.86M | $1.51B | +1 | −2 |
| Q2 2024 | 13 | n/a | 11.86M | $1.24B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 13.52M | -4.0% | $1.18B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passive) | 9.25M | +4.4% | $810.41M | 0.0% | ▲ Add | 2 | SEC ↗ ×19 |
| 3 | T. Rowe Price ✦ | 8.17M | +2.4% | $716.28M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (passive) | 4.95M | -1.4% | $433.51M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 2.96M | -0.6% | $258.23M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 2.19M | n/a | $192.34M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 7 | PRIMECAP Management ✦ | 1.33M | -2.0% | $116.82M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 1.02M | n/a | $89.64M | 0.0% | n/c | 1 | SEC ↗ ×30 |
| 9 | Goldman Sachs Group ✦ | 486.35K | n/a | $42.63M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 10 | Arrowstreet Capital ✦ | 256.32K | +430.8% | $22.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 132.61K | -36.7% | $11.62M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 12 | Gotham Asset Management ✦ | 127.86K | +27.8% | $11.21M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 105.69K | New | $9.26M | 0.0% | New | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 89.62K | +210.2% | $7.86M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 27.65K | +114.7% | $2.42M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 16 | Wellington Management ✦ | 24.34K | +4.9% | $2.13M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | AQR Capital Management ✦ | 17.86K | +7.1% | $1.52M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 18 | Two Sigma Investments ✦ | 17.05K | +555.0% | $1.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Fisher Asset Management ✦ | 15.56K | 0.0% | $1.36M | 0.0% | ▲ Add | 6 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Adage Capital Partners | $9.26M | 0.0% |
Exited
| Norges Bank | $124.57M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 495 holders, 115.11M shares, $7.19B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.63K sh · $235,728
Officer · 7.33K sh · $1.03M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology